First-in-Class Anti-sMIC Immunotherapy Antibody Therapy to Target Prostate Cancer Metastasis November 6, 2019 For the past 15 years, Dr. Jennifer Wu and her research team have been investigating the mechanisms driving prostate cancer progression and developing novel treatments and models to combat metastasis. With the support of an FY05 Idea Development Award, Dr. Wu has mechanistically examined how cancer cells have been able to bypass immune cells and survive. Her work began by discovering that in advanced stages of prostate cancer, the cancer cells could not only escape immune system surveillance, but could also disable the immune system response.Read the full article here.Source: Dr. Jennifer Wu - CDMRP Prostate Cancer News
For the past 15 years, Dr. Jennifer Wu and her research team have been investigating the mechanisms driving prostate cancer progression and developing novel treatments and models to combat metastasis. With the support of an FY05 Idea Development Award, Dr. Wu has mechanistically examined how cancer cells have been able to bypass immune cells and survive. Her work began by discovering that in advanced stages of prostate cancer, the cancer cells could not only escape immune system surveillance, but could also disable the immune system response.Read the full article here.Source: Dr. Jennifer Wu - CDMRP
